List of Medical Device Companies in New York - 19

Revolutionizing Diabetes Care: No More Needles! At Apollon Inc., we're changing the game for diabetes management. Imagine checking your blood sugar without a single prick - that's what our new continuous glucose monitoring (CGM) system does. Using cutting-edge Raman spectroscopy, we're making glucose monitoring easy, painless, and affordable for everyone. Our device is as small as a smartwatch, needle-free, and designed with your safety in mind. We're currently working with MIT to perfect it, bringing together the best talent from Boston to Seoul. Diabetes affects millions worldwide, and we're here to make their lives better. Our goal? To help more people manage their health easily and comfortably. Join us in this exciting journey. Together, we can improve lives, one simple glucose check at a time. Let's make diabetes management stress-free for everyone!

Beyond Air Inc. is a commercial stage medical device and biopharmaceutical company focused on harnessing nitric oxide therapy. The company is built on a legacy of innovation and is revolutionizing nitric oxide therapy. Beyond Air Inc. has experience and leadership that go beyond, with a team of industry professionals dedicated to advancing medical treatment. For more information, visit https://www.beyondair.net/

Casana is innovating healthcare delivery with a smart toilet seat that enables effortless, integrated, and consistent in-home health monitoring. The FDA-cleared Heart Seat® captures heart rate and blood oxygenation. The healthcare system has been searching for this actionable intelligence for decades, and it turns out, we were sitting on a great idea all along. The Heart Seat will become commercially available upon future clearance of non-invasive blood pressure.

Clarapath is a medical robotics company automating the laboratory. Our first product is focused on automating the microtomy station in pathology. Our vision is to innovate, standardize, and digitally transform anatomic pathology through higher quality lab medicine, more robust safety standards, increased lab throughput, while lowering laboratory costs and labor related delays.

Perfecting the Sense of Sight. Clerio Vision is developing a revolutionary product platform for the global ophthalmic market, based on technology licensed from the University of Rochester. The company is in the process of developing and commercializing a portfolio of next generation products in contact lenses, myopia control and cataract surgery. The team is composed of serial entrepreneurs with multiple exits as well as ophthalmic industry veterans who pioneered a number of new ophthalmic technology categories. The products are currently in clinical development.

Eyenovia, Inc. (NASDAQ: EYEN) is a specialty biopharmaceutical company building a portfolio of next generation topical eye treatments based on its proprietary delivery and formulation platform for microdosing. Eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for myopia progression, presbyopia, mydriasis and other eye diseases.

Welcome to the future of neurological assessments with Firefly Neuroscience’s FDA-cleared Brain Network Analytics (BNA™). Utilizing ADVANCED AI and an extensive proprietary EEG database, BNA™ combines the automatic analysis of Event-Related Potentials (ERPs), spectral EEG, and behavioral performance data for a comprehensive and objective data-driven brain health evaluation.

Lilu, Inc. is a women's health company based in New York, founded in May 2016. The company specializes in tech-enabled products that support new mothers during postpartum care. Lilu focuses on making breastfeeding, pumping, and early motherhood more efficient and comfortable. Their team of four has developed patented pneumatic massage technology to help address lactation challenges. The flagship product, the Lilu Massage Bra, is the first automated breast massage pumping bra. It uses compression massage technology to enhance milk output during pumping sessions. Additionally, Lilu offers the MilkSense App, currently in beta, which helps mothers track breast milk production and optimize their feeding routines. Lilu emphasizes user-centered design and aims to empower mothers through innovative solutions that improve postnatal care.

NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low intensity acoustic technology. The company's patented technology allows for creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible material surfaces. This unique development may be utilized for a variety of medical requiring low cost therapeutic ultrasound applications. The company's patch based product diagnosis, PainShield®, carries an FDA clearance. NanoVibronix catheter based products include the CathbotTM . NanoVibronix Inc. is located in Elmsford, NY. Its subsidiary, NanoVibronix Ltd. is located in Nesher, Israel.

We make sure great products get made. Too many great product ideas never get made. Natech ensures our clients' innovative ideas are manufactured so they can get started on their next great idea. As an injection molder and contract manufacturer, Natech specializes in an engineering-focused approach to manufacturing. Our core team are experts in design for manufacturing, assembly and scaling new products. Natech is an ISO 9001, ISO 13485 and FDA-registered molder. Headquartered in Long Island, NY, Natech operates three facilities, including a class 8 cleanroom for medical molding and assembly. Natech Plastics serves the medical, diagnostics, electronics, consumer goods and packaging markets. Contact a Natech engineer to get started on your new product.

Overture Life is a clinical-stage biotechnology company whose mission is to automate assisted reproductive processes to improve IVF pregnancy outcomes through process automation and non-invasive embryo selection. Its revolutionary technologies help standardize fertility treatments, by simplifying techniques and optimizing resources to make reproductive technologies more affordable, reliable, and accessible. Founded by recognized global leaders in embryo genetic testing and assisted reproduction, Overture is backed by Khosla Ventures, Felicis Ventures, Octopus Ventures and GV, and maintains offices in the U.S. and Spain.

PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. We are building the only brain–computer interface that is designed to be minimally invasive, safely removable, and capable of processing large amounts of data.

Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women's health benefits solution, trusted by the nation's leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians. Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs. Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.

RegenLab is recognized as a global leader in medical biotechnologies, specializing in cellular therapies, manufactured in the USA. RegenLab is at the forefront of innovation, with an expertly designed medical device for the preparation of platelet rich plasma from the patient's own blood. Regen® A-PRP® is FDA cleared and developed with a focus on product quality, patient safety, and preparation efficiency. Our patient-centered technology has led to over one million treatments worldwide using RegenLab products. As we look to the future, we are committed to guiding new standards for emerging categories within the field of regenerative medicine.

We are developing a novel device to prevent infection in peritoneal dialysis, a form of at-home treatment for end-stage renal disease. By minimizing the risk of infection, we enable more patients with kidney failure to receive quality care in the comforts of their own homes.

SmartZyme is a life science company using PROVOLUTION™ , a proprietary technological platform for protein design and engineering, in accordance with industry required specifications. The company was founded in November 2013 by Shilo Ben Zeev (CEO) and David Baram, Ph.D. (CTO). The company aims to efficiently design and create proteins and potent enzymes with the specific characteristics required for optimal performance. Its products will be used to revolutionize industries by addressing unmet needs of various industrial fields. The company’s PROVOLUTION™ technology combines some of the most advanced scientific tools for protein engineering, computational biology and electrochemistry. These tools enable the development of improved, or “superior”, proteins and enzymes for wide ranging applications. The Company is currently focusing on the Diabetes market where it intends to launch its first two products: a pre-designed enzyme with superior characteristics for improved bio-electrochemical glucose catalysis, to be used on glucose test strips for the Self Monitoring Blood Glucose (SMBG) market. Strip manufacturers incorporating this superior enzyme in their products will be able to offer results which are far more accurate than current standard strips and ensure that their strips meet the rigid ISO 15197:2013 requirements. The company’s second product, the Go Patch Go™, personalized patient care system (PCS), an on-demand blood glucose measurement system in which measurement accuracy, enzyme stability and product shelf life are significantly enhanced due to the use of SmartZyme’s protein engineering technology. This product will offer diabetic patients a solution to current blood glucose monitoring systems which lack the optimal accuracy and stability required for effective treatment for diabetes. SmartZyme’s R&D efforts are supported by a scientific advisory board of leaders in the fields of protein engineering, structural biology and electrochemistry.

At Synaptrix, we are pioneering accessible technologies to empower individuals with paralysis to live more independently. Our first device, Neuralis™, is a non-invasive, EEG based neural interface that allows paralyzed individuals to control the wheelchair they already use with their brain activity and eye movements. By interpreting signals from visual cortex, Neuralis™ enables intuitive and effortless wheelchair navigation. Neuralis™ is specially designed to meet the needs of paralyzed patients with conditions like ALS, spinal cord injury, MS, strokes, and other neurodegenerative conditions. It provides an affordable alternative to complex, expensive solutions that are often impractical for daily independence. At Synaptrix, we are committed to improving the quality of life for individuals with physical limitations. Through our research, we seek to contribute to the advancement of assistive technologies for patients with neurological conditions, emphasizing the importance of regaining autonomy and control over their lives.

The eye is the window into the body. Identifeye Health is creating a non-invasive test that detects health conditions through the eyes. Identifeye Health is part of the 4Catalyzer accelerator, with over $700 Million in funding, 300 scientists and engineers. Our offices are in Guilford CT, New York City, and Palo Alto. 4Catalyzer is founded by Jonathan Rothberg, the inventor of "Next-Gen" DNA sequencing and ultrasound-on-a-chip (Butterfly Network).